BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 28192212)

  • 21. Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.
    Cai S; Cao J; Yu T; Xia M; Peng J
    Medicine (Baltimore); 2017 Jun; 96(22):e7021. PubMed ID: 28562554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
    Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
    Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
    Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X
    Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
    Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
    World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma.
    Shin HS; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Baatarkhuu O; Ahn SH
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1528-34. PubMed ID: 22497450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
    Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
    Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
    Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
    Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
    Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
    Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
    Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R
    J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
    Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
    Huang KL; Lai YK; Lin CC; Chang JM
    World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
    J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
    Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
    J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Law ST; Lee MK; Li KK; Mok CK
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):193-8. PubMed ID: 26587867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
    Lin M; Yang LY; Li WY; Peng YP; Zheng JK
    J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2.
    Tian JH; Liu WD; Zhang ZY; Tang LH; Li D; Tian ZJ; Lin SW; Li YJ
    J Viral Hepat; 2019 Apr; 26(4):496-505. PubMed ID: 30521133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.